We show that increase of PGC-like cell formation by SMAD2 loss promotes liver metastasis, while genetical depletion of PGC-specific genes or pharmacological inactivation of BMP pathways markedly reduces PGC-like tumor cells leading to the impairment of liver metastasis. Here, SMAD2 is linked to neoplasm.